Dermata Therapeutics Inc.

NASDAQ: DRMAW · Real-Time Price · USD
0.02
0.00 (29.03%)
At close: Jun 09, 2025, 3:06 PM

Dermata Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-11.65M -12.51M -11.53M -10.12M -8.97M -8.04M -7.53M -8.17M -9.17M -9.67M -10.52M -9.78M -8.38M -7.86M -5.8M -4.62M -4.09M
Interest Income
192.7K 225.78K 262.29K 302.56K 278.97K 247.22K 203.44K 132.16K 101.11K 63.57K 21.49K n/a n/a n/a n/a n/a n/a
Pretax Income
-11.46M -12.29M -11.27M -9.82M -8.69M -7.79M -7.33M -8.04M -9.06M -9.61M -10.49M -9.78M -8.38M -7.9M -5.75M -4.63M -4.12M
Net Income
-11.46M -12.29M -11.27M -9.82M -8.69M -7.79M -7.25M -7.91M -8.94M -9.48M -10.45M -9.78M -8.38M -7.9M -5.75M -4.63M -4.12M
Selling & General & Admin
3.77M 4.31M 4.39M 4.47M 4.49M 3.97M 3.71M 3.69M 3.92M 4.02M 4.64M 4.66M 4.01M 4.4M 3.33M 2.84M 2.76M
Research & Development
7.88M 8.2M 7.15M 5.65M 4.48M 4.07M 3.82M 4.47M 5.25M 5.65M 5.87M 5.12M 4.37M 3.46M 2.46M 1.78M 1.33M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
11.65M 12.51M 11.53M 10.12M 8.97M 8.04M 7.53M 8.17M 9.17M 9.67M 10.52M 9.78M 8.38M 7.86M 5.8M 4.62M 4.09M
Interest Expense
n/a n/a 37.54K 37.54K 37.54K 37.54K 42.09K 63.57K 63.57K 63.57K 45.59M 45.57M 45.57M 45.61M 84.09K 140.77K 167.81K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
9.31M 12.51M 11.53M 10.12M 8.97M 8.04M 7.53M 8.17M 9.17M 9.67M 10.52M 9.78M 8.38M 7.86M 5.8M 4.62M 4.09M
Income Tax Expense
3.2M n/a -3.21M -3.21M -3.21M -5.76K -87.72K -128.88K -2.86M -5.64M -51.13M -51.08M -48.35M -45.57M 78.22K 25.55K -25.49K
Shares Outstanding (Basic)
5.15M 1.55M 1.55M 676.57K 444.06K 3.93M 3.19M 2.7M 65.72K 770.12K 767.27K 699.68K 520.54K 8.35M 311.27K 469.74K 520.54K
Shares Outstanding (Diluted)
5.15M 1.55M 1.55M 676.57K 444.06K 3.93M 3.19M 2.7M 65.72K 770.12K 767.27K 699.68K 522.03K 8.35M 311.27K 469.74K 520.54K
EPS (Basic)
-8.71 -15.32 -13.82 -12.32 -8.77 -35.79 -37.31 -39.87 -43.14 -14.41 -12.66 -15.06 -14 -13.08 -12.82 -8.47 -7.21
EPS (Diluted)
-8.71 -15.32 -13.82 -12.32 -8.77 -35.79 -37.31 -39.87 -43.14 -14.4 -12.65 -15.05 -13.99 -13.08 -12.82 -8.47 -7.21
EBITDA
-11.65M -9.31M -8.24M -6.83M -5.68M -7.96M -5.82M -6.46M -7.45M -7.96M -10.52M -9.78M -8.38M -7.86M -5.66M -4.49M -3.95M
EBIT
-9.31M -12.51M -11.53M -10.12M -8.97M -8.04M -7.53M -8.17M -9.17M -9.67M -10.52M -9.78M -8.38M -7.86M -5.66M -4.49M -3.95M
Depreciation & Amortization
n/a 3.2M 5.42M 7.24M 8.97M 5.76M 5.26M 5.89M 6.89M 9.67M 7.96M 5.52M 2.79M 324.00 133.84K 186.5K 237.54K